These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34831195)

  • 1. Harnessing CD8
    Ceeraz S; Thompson CR; Beatson R; Choy EH
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells.
    Fenoglio D; Ferrera F; Fravega M; Balestra P; Battaglia F; Proietti M; Andrei C; Olive D; Antonio LC; Indiveri F; Filaci G
    Hum Immunol; 2008 Nov; 69(11):745-50. PubMed ID: 18832002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice.
    Ménager-Marcq I; Pomié C; Romagnoli P; van Meerwijk JP
    Gastroenterology; 2006 Dec; 131(6):1775-85. PubMed ID: 17087950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival.
    Liu H; Qiu F; Wang Y; Zeng Q; Liu C; Chen Y; Liang CL; Zhang Q; Han L; Dai Z
    Front Immunol; 2019; 10():306. PubMed ID: 30863408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo dynamical interactions between CD4 Tregs, CD8 Tregs and CD4+ CD25- cells in mice.
    Arazi A; Sharabi A; Zinger H; Mozes E; Neumann AU
    PLoS One; 2009 Dec; 4(12):e8447. PubMed ID: 20041142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective CD8+CD28+ regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy.
    Ceeraz S; Hall C; Choy EH; Spencer J; Corrigall VM
    Clin Exp Immunol; 2013 Oct; 174(1):18-26. PubMed ID: 23786396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel CD28 antagonist mPEG PV1-Fab' mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-γ production.
    Papotto PH; Marengo EB; Sardinha LR; Carvalho KI; de Carvalho AE; Castillo-Mendez S; Jank CC; Vanhove B; Goldberg AC; Rizzo LV
    PLoS One; 2017; 12(3):e0171822. PubMed ID: 28248972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation.
    Mikami N; Kawakami R; Chen KY; Sugimoto A; Ohkura N; Sakaguchi S
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12258-12268. PubMed ID: 32414925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8
    Niederlova V; Tsyklauri O; Chadimova T; Stepanek O
    Eur J Immunol; 2021 Mar; 51(3):512-530. PubMed ID: 33501647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer.
    Liu C; Hu Q; Hu K; Su H; Shi F; Kong L; Zhu H; Yu J
    J Transl Med; 2019 Apr; 17(1):120. PubMed ID: 30971280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric antigen receptor costimulation domains modulate human regulatory T cell function.
    Boroughs AC; Larson RC; Choi BD; Bouffard AA; Riley LS; Schiferle E; Kulkarni AS; Cetrulo CL; Ting D; Blazar BR; Demehri S; Maus MV
    JCI Insight; 2019 Mar; 5(8):. PubMed ID: 30869654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.
    Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M
    Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.
    Selck C; Dominguez-Villar M
    Front Immunol; 2021; 12():661875. PubMed ID: 34054826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B Cells Drive Autoimmunity in Mice with CD28-Deficient Regulatory T Cells.
    Zhang R; Sage PT; Finn K; Huynh A; Blazar BR; Marangoni F; Mempel TR; Sharpe AH; Turka LA
    J Immunol; 2017 Dec; 199(12):3972-3980. PubMed ID: 29093061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
    Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
    Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
    Peterson LB; Bell CJM; Howlett SK; Pekalski ML; Brady K; Hinton H; Sauter D; Todd JA; Umana P; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Klein C; Hosse RJ; Wicker LS
    J Autoimmun; 2018 Dec; 95():1-14. PubMed ID: 30446251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells.
    Tanaka H; Zhang W; Yang GX; Ando Y; Tomiyama T; Tsuneyama K; Leung P; Coppel RL; Ansari AA; Lian ZX; Ridgway WM; Joh T; Gershwin ME
    Clin Exp Immunol; 2014 Nov; 178(2):253-61. PubMed ID: 25041369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunity.
    Wright GP; Ehrenstein MR; Stauss HJ
    Expert Rev Clin Immunol; 2011 Mar; 7(2):213-25. PubMed ID: 21426259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The change of periphery and centra CD4(+);CD25(+);Treg, CD8(+);CD28(-);Treg in the MOG induced model of experimental autoimmune encephalomyelitis].
    Shang XF; Xi NN; Wang T; Lv J; Han Z; Zheng RY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Aug; 26(8):746-9. PubMed ID: 20619099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma.
    Meloni F; Morosini M; Solari N; Passadore I; Nascimbene C; Novo M; Ferrari M; Cosentino M; Marino F; Pozzi E; Fietta AM
    Hum Immunol; 2006; 67(1-2):1-12. PubMed ID: 16698419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.